Clinical Trial Update: Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating short-term Endothelin A receptor blockade in patients undergoing on-pump coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endothelin A receptor blocker (Endothelin A receptor antagonist)

Snippet

Sponsor: Medical University of Vienna | Conditions: Coronary Artery Disease, Aorto-coronary Bypass Grafting | Phase 2 | Status: UNKNOWN